Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on the company. StockNews.com upgraded Core Laboratories from a "sell" rating to a "hold" rating in a research note on Wednesday, May 11th. Stifel Nicolaus dropped their target price on Core Laboratories from $26.00 to $20.00 in a research report on Tuesday, July 26th. Finally, Morgan Stanley dropped their target price on Core Laboratories from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Monday, August 1st.
Core Laboratories Trading Down 2.7 %
CLB Stock opened at $16.15 on Wednesday. The company has a current ratio of 2.08, a quick ratio of 1.53 and a debt-to-equity ratio of 1.08. Core Laboratories has a 12-month low of $15.21 and a 12-month high of $35.83. The stock has a market cap of $748.15 million, a price-to-earnings ratio of 85.00, a PEG ratio of 0.78 and a beta of 2.60. The business's 50-day moving average is $19.00 and its 200 day moving average is $25.17.
Core Laboratories (NYSE:CLB - Get Rating) last posted its quarterly earnings data on Wednesday, July 27th. The oil and gas company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.02). Core Laboratories had a return on equity of 16.12% and a net margin of 1.82%. The firm had revenue of $120.90 million during the quarter, compared to analyst estimates of $121.35 million. During the same quarter in the previous year, the firm posted $0.18 earnings per share. The company's quarterly revenue was up 1.8% on a year-over-year basis. On average, sell-side analysts anticipate that Core Laboratories will post 0.54 EPS for the current fiscal year.
Core Laboratories Cuts Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 29th. Investors of record on Monday, August 8th will be issued a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.25%. The ex-dividend date is Friday, August 5th. Core Laboratories's payout ratio is 21.05%.